
 
 
 
 
 
 
 
 
  Claims  
   
 1.    A recombinant cell for the production of legionaminic acid, comprising:  an inactivated GlcNAc-6-P deacetylase gene; a gene encoding a UDP-GlcNAc 4,6-dehydratase that is capable of converting UDP-GlcNAc into UDP-2-acetamido-2,6-dideoxy-a-D-xy/o-hexos-4-ulose; a gene encoding an aminotransferase that is capable of converting UDP-2-acetamido-2,6-dideoxy-a-D-xy/o-hexos-4-ulose into UDP-4-amino-4,6-dideoxy-a-D-GlcNAc or acetamido-4-amino-2,4,6-trideoxy-a-D-Glc; a gene encoding an N-acetyltransferase that is capable of converting UDP-4-amino-4,6-dideoxy-a-D-GlcNAc or UDP-2-acetamido-4-amino-2,4,6-trideoxy-a-D-Glc into UDP-2,4-diacetamido-2,4,6-trideoxy-a-D-Glc (UDP-BacdiNAc); a gene encoding a Leg synthase that is capable of converting 2,4-diacetamido-2,4,6-trideoxy-D-Man (6-deoxy-MandiNAc) into 5,7-diacetamido-3,5,7,9-tetradeoxy-D-glycero-D-galacto-nonulosonic acid (Leg); a gene encoding a UDP-sugar hydrolase and 2-epimerase that is capable of converting UDP-2,4-diacetamido-2,4,6-trideoxy-a-D-Glc (UDP-BacdiNAc) into 2,4-diacetamido-2,4,6-trideoxy-D-Man (6-deoxy-MandiNAc); a gene encoding a GicNAc-6-P mutase; and a gene encoding a GicNAc-1-P uridyltransferase.  
 
     
 2.    The recombinant cell of claim 1, wherein the genes encoding the UDP-GicNAc 4,6-dehydratase, the aminotransferase, and the N-acetyltransferase are genes from C. jejuni; the gene encoding the Leg synthase is from C. jejuni or L. pneumophila; the gene encoding the UDP-sugar hydrolase and 2-epimerase is a gene from L. pneumophila; and the genes encoding the GlcNAc-6-P mutase and the GlcNAc-1-P uridyltransferase are from S.  cerevisfae.  
 
     
 3.    The recombinant cell of claim 1 or 2, further comprising an inactivated sialic acid transporter gene, an inactivated sialic acid aldolase gene, or a combination thereof.   Date Recue/Date Received 2022-03-30  
 
     
 4.    The recombinant cell of claim 3, wherein the inactivated sialic acid transporter gene is nan Tend the inactivated sialic acid aldolase gene is nanA.  
 
     
 5.    The recombinant cell of any one of claims 1 to 4, wherein the cell is an E. coli cell.  
 
     
 6.    The recombinant cell of claim 1, wherein the recombinant cell is an E.  coli cell and comprises an inactivated nanT sialic acid transporter gene, an inactivated nanA sialic acid aldolase gene, an inactivated nagA GIcNAc-6-P deacetylase gene, a PgIF gene encoding SEQ  ID NO:6, a PgIE gene encoding SEQ ID NO:7, a PgID gene encoding SEQ ID NO:8, a Legl gene encoding SEQ ID NO:9 or SEQ ID NO:10, a LegG gene encoding SEQ ID NO:11, the agm1 GIcNAc-6-P mutase gene, and the uapl GIcNAc-1-P uridyltransferase gene.  
 
     
 7.    The recombinant cell of any of claims 1 to 6, further comprising an inactivated ManNAc-6-P epimerase gene, an inactivated undecaprenyl-P/UDP-GIcNAc transferase gene, or a combination thereof.  
 
     
 8.    The recombinant cell of claim 7, wherein the ManNAc-6-P epimerase gene is nanE and the undecaprenyl-P/UDP-GIcNAc transferase gene is wecA.  
 
     
 9.    The recombinant cell of any one of claims 1 to 8, further comprising a gene encoding acetyl-CoA synthase.  
 
     
 10.    The recombinant cell of claim 1, further comprising at least one of an inactivated nanT  sialic acid transporter gene, an inactivated nanA sialic acid aldolase gene, an inactivated wecA  undecaprenyl-PIUDP-GIcNAc transferase gene, an inactivated nanE ManNAc-6-P  epimerase gene, and a gene encoding an acetyl-CoA synthase.  
 
     
 11.    A method for the production of legionaminic acid, comprising growing the recombinant cell of any one of claims 1 to 10 and recovering the produced legionaminic acid.  
 
     
 12.    The method of claim 11, wherein the recombinant cell is grown in a growth medium supplemented with palmitate.  
 
     
 13.    A recombinant cell for the production of UDP-2,4-diacetamido-2,4,6-trideoxy-a-D-glucopyranose (UDP-BacdiNAc), comprising: an inactivated GIcNAc-6-P deacetylase gene;   Date Recue/Date Received 2022-03-30 a gene encoding a UDP-GlcNAc 4,6-dehydratase that is capable of converting UDP-GlcNAc into UDP-2-acetamido-2,6-dideoxy-a-D-xy/o-hexos-4-ulose; a gene encoding an aminotransferase that is capable of converting UDP-2-acetamido-2,6-dideoxy-a-D-xylo-hexos-4-ulose into UDP-4-amino-4,6-dideoxy-a-D-GlcNAc or acetamido-4-amino-2,4,6-trideoxy-a-D-Glc; a gene encoding an N-acetyltransferase that is capable of converting UDP-4-amino-4,6-dideoxy-a-D-GlcNAc or UDP-2-acetarnido-4-amino-2,4,6-trideoxy-a-D-Gic into UDP-2,4-diacetamido-2,4,6-trideoxy-a-D-Glc (UDP-BacdiNAc); a gene encoding a GlcNAc-6-P mutase; and a gene encoding a GlcNAc-1-P uridyltransferase.  
 
     
 14.    The recombinant cell of claim 13, wherein the genes encoding the UDP-GlcNAc 4,6-dehydratase, the aminotransferase, and the N-acetyltransferase are from C.  jejuni, and the genes encoding the GlcNAc-6-P mutase and the GlcNAc-1-P uridyltransferase are from S.  cerevisiae.  
 
     
 15.    The recombinant cell of claim 13 or 14, further comprising an inactivated sialic acid transporter gene, an inactivated sialic acid aldolase gene, or a combination thereof.  
 
     
 16.    The recombinant cell of claim 15, wherein the sialic acid transporter gene is nanT and the sialic acid aldolase gene is nanA.  
 
     
 17.    The recombinant cell of any one of claims 13 to 16, further comprising an inactivated undecaprenyl-P/U0P-GlcNAc transferase gene.  
 
     
 18.    The recombinant cell of any one of claims 13 to 17, further comprising a gene encoding acetyl-CoA synthase.  
 
     
 19.    The recombinant cell of claim 17 or 18, wherein the undecaprenyl-P/UDP-GlcNAc transferase gene is wecA.  
 
     
 20.    The recombinant cell of any one of claims 13 to 19, wherein the cell is an E. colicell.  
 
     
 21.    The recombinant cell of claim 13, wherein the recombinant cell is an E.  coli cell and comprises an inactivated nanT sialic acid transporter gene, an inactivated nanA sialic acid Date Recue/Date Received 2022-03-30 aldolase gene, an inactivated nagA GIchlAc-6-P deacetylase gene, a PgIF gene encoding SEQ  ID NO:6, a PgIE gene encoding SEQ ID NO:7, a PgID gene encoding SEQ ID NO:8, the agml GIcNAc-6-P mutase gene, and the uapl GIcNAc-1-P uridyltransferase gene.  
 
     
 22.    The recombinant cell of claim 13, further comprising at least one of an inactivated nanT  sialic acid transporter gene, an inactivated nanA sialic acid aldolase gene, an inactivated wecA  undecaprenyl-P/UDP-GIcNAc transferase gene, and a gene encoding acetyl-CoA  synthase.  
 
     
 23.    A method for the production of UDP-2,4-diacetamido-2,4,6-trideoxy-a-D-glucopyranose (UDP-BacdiNAc), comprising growing the recombinant cell of any one of claims 13 to 22 and recovering the produced UDP-BacdiNAc.  
 
     
 24.    The method of claim 23, wherein the recombinant cell is grown in a growth medium that is supplemented with palmitate.  
 
     
 25.    A recombinant cell for the production of UDP-BacdiNAc, wherein the recombinant cell is of the strain deposited at the International Depository Authority of Canada (IDAC) on April 7, 2011 under deposit number 060411-01.   Date Recue/Date Received 2022-03-30  
 
   
 
 
 
 
 
 
 
 
